pentaerythritol tetranitrate has been researched along with Body Weight in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crouse, LC; Johnson, MS; LaFiandra, EM; McFarland, CA; Quinn, MJ | 1 |
| Fáberová, V; Kristek, F; Varga, I | 1 |
| Bucher, JR; Eustis, SL; Haseman, JK; Huff, J; Lilja, HS; Murthy, AS | 1 |
3 other study(ies) available for pentaerythritol tetranitrate and Body Weight
| Article | Year |
|---|---|
Reproductive and developmental effects and physical and chemical properties of pentaerythritol tetranitrate (PETN) in the rat.
Topics: 1-Octanol; Administration, Oral; Animals; Biodegradation, Environmental; Body Weight; Dose-Response Relationship, Drug; Environmental Exposure; Environmental Pollutants; Female; Fetal Development; Gonads; Male; Pentaerythritol Tetranitrate; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Sex Ratio; Solubility; Vasodilator Agents | 2009 |
Long-term effect of molsidomine and pentaerythrityl tetranitrate on cardiovascular system of spontaneously hypertensive rats.
Topics: Animals; Aorta; Aorta, Thoracic; Blood Platelets; Blood Pressure; Body Weight; Cardiovascular System; Carotid Arteries; Coronary Vessels; Cyclic GMP; Heart Rate; Hypertension; Male; Molsidomine; Nitric Oxide Donors; Nitric Oxide Synthase; Organ Size; Pentaerythritol Tetranitrate; Random Allocation; Rats; Rats, Inbred SHR; Rats, Wistar; Time Factors; Treatment Outcome; Vasodilator Agents | 2003 |
No evidence of toxicity or carcinogenicity of pentaerythritol tetranitrate given in the diet to F344 rats and B6C3F1 mice for up to two years.
Topics: Animals; Body Weight; Carcinogens; Diet; Female; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred Strains; Pentaerythritol Tetranitrate; Rats; Rats, Inbred F344; Sebaceous Gland Neoplasms; Species Specificity | 1990 |